Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Zhenhao Fang; Lei Peng; Carolina Lucas; Qianqian Lin; Liqun Zhou; Luojia Yang; Yanzhi Feng; Ping Ren; Paul A Renauer; Valter S Monteiro; Anne M Hahn; Jonathan J Park; Xiaoyu Zhou; Yale SARS-CoV-2 Genomic Surveillance Initiative; Nathan D Grubaugh; Craig B Wilen; Sidi Chen

doi:10.1038/s41421-022-00435-w

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

Cell Discov. 2022 Jul 19;8(1):69. doi: 10.1038/s41421-022-00435-w.

Authors

Zhenhao Fang^#^{1

2

3}, Lei Peng^#^{1

2

3}, Carolina Lucas⁴, Qianqian Lin^{1

2

3}, Liqun Zhou^{1

2

3

5}, Luojia Yang^{1

2

3

6}, Yanzhi Feng^{1

2

3

5}, Ping Ren^{1

2

3}, Paul A Renauer^{1

2

3

6}, Valter S Monteiro^{4

5}, Anne M Hahn^{7

8}, Jonathan J Park^{1

2

3

9}, Xiaoyu Zhou^{1

2

3}; Yale SARS-CoV-2 Genomic Surveillance Initiative; Nathan D Grubaugh^{7

8}, Craig B Wilen^{4

10}, Sidi Chen^{11

12

13

14

15

16

17

18

19}

Collaborators

Yale SARS-CoV-2 Genomic Surveillance Initiative:
Kendall Billig, Mallery I Breban, Christopher Castaldi, Chrispin Chaguza, Nicholas Chen, David Ferguson, Nicholas Kerantzas, Tobias R Koch, Bony De Kumar, Marie L Landry, David Peaper, Kien Pham, Wade Schulz, Irina R Tikhonova, Chantal B F Vogels

Affiliations

¹ Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
² System Biology Institute, Yale University, West Haven, CT, USA.
³ Center for Cancer Systems Biology, Yale University, West Haven, CT, USA.
⁴ Department of Immunobiology, Yale University, New Haven, CT, USA.
⁵ Immunobiology Program, Yale University, New Haven, CT, USA.
⁶ Molecular Cell Biology, Genetics, and Development Program, Yale University, New Haven, CT, USA.
⁷ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
⁸ Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA.
⁹ MD-PhD Program, Yale University, New Haven, CT, USA.
¹⁰ Department of Laboratory Medicine, Yale University, New Haven, CT, USA.
¹¹ Department of Genetics, Yale University School of Medicine, New Haven, CT, USA. sidi.chen@yale.edu.
¹² System Biology Institute, Yale University, West Haven, CT, USA. sidi.chen@yale.edu.
¹³ Center for Cancer Systems Biology, Yale University, West Haven, CT, USA. sidi.chen@yale.edu.
¹⁴ Immunobiology Program, Yale University, New Haven, CT, USA. sidi.chen@yale.edu.
¹⁵ Molecular Cell Biology, Genetics, and Development Program, Yale University, New Haven, CT, USA. sidi.chen@yale.edu.
¹⁶ MD-PhD Program, Yale University, New Haven, CT, USA. sidi.chen@yale.edu.
¹⁷ Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT, USA. sidi.chen@yale.edu.
¹⁸ Stem Cell Center, Yale University School of Medicine, New Haven, CT, USA. sidi.chen@yale.edu.
¹⁹ Center for Biomedical Data Science, Yale University School of Medicine, New Haven, CT, USA. sidi.chen@yale.edu.

^# Contributed equally.

No abstract available

Grants and funding